Identification of tyrosine kinases overexpressed in head and neck cancer

被引:37
作者
Lin, HS
Berry, GJ
Fee, WE
Terris, DJ
Sun, ZJ
机构
[1] Wayne State Univ, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48201 USA
[2] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Med Ctr, Div Otolaryngol, Stanford, CA 94305 USA
[4] Med Coll Georgia, Dept Otolaryngol, Augusta, GA 30912 USA
关键词
D O I
10.1001/archotol.130.3.311
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To identify protein-tyrosine kinases (PTKs) that may be involved in the development and progression of head and neck squamous cell carcinoma (HNSCC). Design: Messenger RNA from 7 HNSCC specimens was reverse transcribed to complementary DNA, and selective amplification of PTK complementary DNA was achieved using polymerase chain reaction (PCR) with degenerate PTK primers. The resulting PTK PCR products from these 7 HNSCC specimens were then cloned and randomly selected for sequencing. The PTKs that were represented multiple times in these randomly selected clones were selected as candidate PTKs that may be overexpressed in HNSCC. Antibodies against these candidate PTKs were then used for immunohistochemical studies on 8 other HNSCC specimens not used in the original selection of the candidate PTKs. Results: Three known (EphAl, Brk, and Ron) and 2 novel (KIAA0728 and KIAA0279) PTKs were found to be highly expressed in the 7 HNSCC samples studied, based on the technique of reverse transcriptase PCR with degenerate primers. Immunohistochemical studies with antibodies against the 3 known PTKs in 8 other HNSCC specimens not used in the previous reverse transcriptase-PCR reaction demonstrated overexpression of EphA1, Brk, and Ron in 12.5%, 37.5%, and 75% of these specimens. Conclusions: In this study, we identified 5 PTKs that were overexpressed in HNSCC using a reverse transcriptase-PCR technique and confirmed the overexpression of 3 known PTKs in some of the 8 archival HNSCC specimens studied. Our finding suggests that the signaling pathways mediated through EphA1, Brk, and Ron may be involved in the development and progression of HNSCC.
引用
收藏
页码:311 / 316
页数:6
相关论文
共 50 条
  • [11] Emerging tyrosine kinase inhibitors for head and neck cancer
    Bossi, Paolo
    Locati, Laura
    Licitra, Lisa
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (04) : 445 - 459
  • [12] Emerging tyrosine kinase inhibitors for head and neck cancer
    Long, Zhen
    Grandis, Jennifer R.
    Johnson, Daniel E.
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 333 - 344
  • [13] Receptor tyrosine kinases as novel therapeutic targets in head and neck squamous cell carcinoma
    Von Maessenhausen, A.
    Deng, M.
    Vogel, W.
    Queisser, A.
    Perner, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S150 - S150
  • [14] Receptor Tyrosine Kinases as Novel Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
    von Massenhausen, Anne
    Deng, Mario
    Vogel, Wenzel
    Schrock, Andreas
    Queisser, Angela
    Perner, Sven
    [J]. MODERN PATHOLOGY, 2015, 28 : 333A - 333A
  • [15] Receptor Tyrosine Kinases as Novel Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
    von Massenhausen, Anne
    Deng, Mario
    Vogel, Wenzel
    Schrock, Andreas
    Queisser, Angela
    Perner, Sven
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 333A - 333A
  • [16] Tyrosine Kinases in Cancer
    Blau, Olga
    Afanasyev, Boris
    Blau, Igor Wolfgang
    [J]. BIOMARKER INSIGHTS, 2015, 10 : 41 - 42
  • [17] Identification of activated receptor tyrosine kinases in gastric cancer cells
    Yoon, Sang Hyun
    Lee, Myung Eun
    Jeung, Hei-Cheul
    Jung, Jae-Joon
    Kim, Tae Soo
    Chung, Hyun Cheol
    Shin, Sang Joon
    Rha, Sun Young
    [J]. CANCER RESEARCH, 2010, 70
  • [18] Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer
    Kelley, Laura C.
    Shahab, Sohrab
    Weed, Scott A.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (04) : 289 - 304
  • [19] Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer
    Laura C. Kelley
    Sohrab Shahab
    Scott A. Weed
    [J]. Clinical & Experimental Metastasis, 2008, 25 : 289 - 304
  • [20] DRAK1 overexpressed in head and neck cancer suppresses the TGF-β1 tumor suppressor activity in head and neck cancer cells
    Yang, Kyung-Min
    Kim, WonJoo
    Lee, Jeong-Mi
    Kim, Seong-Jin
    [J]. CANCER RESEARCH, 2014, 74 (19)